Showing 1 - 3 results of 3 for search 'Rory Leisegang' Skip to content
    • About the Library
    • Rules and Regulations
    • Library Services
    • Library Hours
  • Library News
    • Digital Repository
    • Google Scholar
    • ResearchGate
    • AJoGPL
    • KURJ
    • AJLS
    • MyLOFT
    • Lexis Plus UK
    • Britannica Academic
    • Research Support Tools
    • Quick Resource Links
  • Login
Advanced
  • Author
  • Rory Leisegang
Showing 1 - 3 results of 3 for search 'Rory Leisegang', query time: 0.01s Refine Results
  1. 1
    Immunogenicity dynamics and covariate effects after satralizumab administration predicted with a hidden Markov model

    Immunogenicity dynamics and covariate effects after satralizumab administration predicted with a hidden Markov model by Rory Leisegang, Hanna E. Silber Baumann, Siân Lennon‐Chrimes, Hajime Ito, Kazuhiro Miya, Jean‐Christophe Genin, Elodie L. Plan

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Novel Versus Conventional Sequencing of β-Blockers, Sodium/Glucose Cotransportor 2 Inhibitors, Angiotensin Receptor-Neprilysin Inhibitors, and Mineralocorticoid Receptor Antagonists in Stable Patients With Heart Failure With Reduced Ejection Fraction (NovCon Sequencing Study): Protocol for a Randomized Controlled Trial

    Novel Versus Conventional Sequencing of β-Blockers, Sodium/Glucose Cotransportor 2 Inhibitors, Angiotensin Receptor-Neprilysin Inhibitors, and Mineralocorticoid Receptor Antagonist... by Sumanth Karamchand, Tsungai Chipamaunga, Poobalan Naidoo, Kiolan Naidoo, Virendra Rambiritch, Kevin Ho, Robert Chilton, Kyle McMahon, Rory Leisegang, Hellmuth Weich, Karim Hassan

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Pharmacokinetics, safety and efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in children with HIV aged from 2 years and weighing at least 14 kg

    Pharmacokinetics, safety and efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in children with HIV aged from 2 years and weighing at least 14 kg by Eva Natukunda, Aditya H. Gaur, Pope Kosalaraksa, Elizabeth Hellström, Renate Strehlau, Afaaf Liberty, Stephanie Cox, Rory Leisegang, Ramesh Palaparthy, Susanne Crowe, Vinicius Vieira, Kathryn Kersey, Natella Rakhmanina

    Published 2025-02-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools:

  • RSS Feed
  • Email Search

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs